13S106: Abstracts: Measures and Measurement of Healthcare Quality (0570–0573)

Abstract Moderator(s)

• 

  Elana Bernstein, MD, MSc

  Columbia University
  New York, NY, United States

  Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)
• 

  Lisa Mandl, MD, MPH

  Hospital for Special Surgery
  New York, NY, United States

  Disclosure(s): Pfizer: Grant/Research Support (Ongoing)

Oral abstract session.

Presentations:

• 8:00 AM – 8:10 AM Eastern Time

  Clarifying Misbeliefs About Hydroxychloroquine (HCQ): Developing an Evidence-Based HCQ Benefits vs. Risk Decision Aid (HCQ-SAFE) Per Low Health Literacy Standards
  

  Presenting Author: Shivani Garg, MD, MS – University of Madison, School of Medicine and Public Health
• 8:10 AM – 8:15 AM Eastern Time

  Q&A
  
• 8:15 AM – 8:25 AM Eastern Time

  National Rollout of a Medication Safety Dashboard to Improve Testing for Latent Infections Among Biologic/targeted Synthetic DMARD Users Within the Veterans Health Administration: Initial Results
  

  Presenting Author: Anna Montgomery, BS, MPH – University of California San Francisco
• 8:25 AM – 8:30 AM Eastern Time

  Q&A
  
• 8:30 AM – 8:40 AM Eastern Time

  ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE
  

  Presenting Author: Patricia Katz, PhD – UCSF
• 8:40 AM – 8:45 AM Eastern Time

  Q&A
  
• 8:45 AM – 8:55 AM Eastern Time

  Telehealth versus Outpatients Clinic Follow up in Rheumatoid Arthritis Patients a Randomized Controlled Study
  

  Presenting Author: Andreas Diamantopoulos, MD, PhD, MPH – Akershus University Hospital
• 8:55 AM – 9:00 AM Eastern Time

  Q&A